Although several protozoa can affect the retina, such as Trypanosomiasis,
Toxoplasma gondii
is the protozoan that most commonly affects the eye. It is the only one that has been associated with CNV. Toxoplasma gondii belongs to the genus Toxoplasma and is a ubiquitous, endocellular parasite in humans. [14] [15] [16] Congenitally acquired toxoplasmosis was originally thought to make up the majority of toxoplasmic retinochoroiditis. This was the case until recently, when most toxoplasmic retinochoroiditis infections were recognised as being acquired. 16, 17 The association between Toxoplasma retinochoroiditis and CNV is frequent and very well known. 6 CNV typically grows close to the edge of an old atrophic scar, even though CNV can occasionally be synchronous with active toxoplasmic retinochoroiditis. FA is useful for the diagnosis of CNV, particularly to distinguish it from the reactivation of retinochoroiditis. The typical angiographic hallmarks of the choroiditis are early hypofluorescence and late staining for the atrophic areas, and late hypofluorescence when pigment clumps are present. The adjacent CNV has the typical dirty grey aspect on fundoscopy, presenting an early hyperfluorescence and late leakage on FA. Optical coherence tomography (OCT) can be useful for the appraisal of CNV, 18 showing liquid within the adjacent or overlying retina. It is also useful for verifying the efficacy of CNV treatment.
As stated earlier, in very rare cases CNV can occur concomitantly with reactivation of retinochoroiditis. As far as treatment is concerned, in the rare cases where CNV is associated with recurrent retinochoroiditis, the classic combination of antitoxoplasmic antibiotics with corticosteroids should be given. 19 The other options available for the treatment of CNV associated with toxoplasmic retinochoroiditis are laser therapy 20 and photodynamic therapy (PDT). 21 At this time, anti-VEGF drugs have shown promising results.
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These techniques can therefore be considered the most reasonable options for such disease.
CNV can be a rare sequela of bacterial infectious choroiditis. [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Choroidal colonisation by the bacteria can occur after bacterial 
Non-infectious Uveitis
Posterior pole non-infectious uveitis can be a severe disease, threatening the visual acuity directly or secondarily by its complications.
MC is the posterior uveitis with the highest rate of CNV formation. It is found in 32-46% of patients.
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In 1973, Nozik and Dorsch 42 described two cases resembling Clinical and angiographic aspects are similar to CNV in MC. As in MC, ICGA is the best modality for proving choroidal involvement, 46 which is usually found to be prominent.
In 1932, Junius 47 described a posterior pole intraocular inflammation presenting a serpiginous pattern. Several reports added more cases in the following years 48,49 and serpiginous choroiditis (SC) became a distinguished entity. SC is a rare, severe, recurrent and, generally, bilateral disease. It is thought to primarily involve the choriocapillaris and secondarily the RPE and the rest of the choroid. 47 The disease typically starts in the peripapillary region and tends to progress centrifugally to the macula, assuming the typical serpiginous pattern.
CNV is a well-known complication of SC and occurs in 10-25% of affected patients. [50] [51] [52] [53] CNV typically occurs near the edge of both active and inactive lesions. FA can be helpful in proving the CNV and should always be • subretinal fibrosis and uveitis syndrome;
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• APMPPE; 56 • birdshot retinochoroidopathy; 57 • multiple evanescent white dots syndrome (MEWDS); [58] [59] [60] • VKH disease; 61 • sympathetic ophthalmia; 62 and
• sarcoidisis. 63 The clinical characteristics of CNV in all of these entities are similar to those observed in other posterior uveitis and are generally type In the case of active inflammation, an infectious disease should be looked for and a suitable therapy offered when available. 
